Albuterol Nebulizer Treatment for Pediatric Asthma

Introduction to Albuterol Nebulizer Treatment

The American Academy of Allergy, Asthma, and Immunology recommends administering albuterol nebulizer solution 2.5 mg (diluted in 3 mL of normal saline) every 4-6 hours as needed for routine bronchodilator therapy, or 2.5 mg every 20 minutes for 3 doses followed by every 1-4 hours as needed during acute asthma exacerbations in children 1, 2

For children weighing ≥15 kg, dilute albuterol to a minimum of 3 mL total volume for optimal nebulization with gas flow of 6-8 L/min 2

For mild-to-moderate exacerbations, administer 2.5 mg every 20 minutes for 3 doses, then continue with 2.5 mg every 1-4 hours as needed based on clinical response 1, 2
For severe exacerbations, use the same 2.5 mg dose every 20 minutes for 3 doses, then hourly, and consider adding ipratropium bromide 0.25 mg to the nebulizer for the first 3 doses 1, 2, 3
The dose may be doubled (5 mg) for severe exacerbations if needed, with a strength of evidence supporting its effectiveness 1

An alternative approach uses 0.15 mg/kg (minimum 2.5 mg) every 20 minutes for 3 doses, then 0.15-0.3 mg/kg every 1-4 hours, with research supporting higher doses (0.30 mg/kg) for severe cases 2, 4

Use oxygen as the driving gas when available, particularly in hypoxic patients, with a strength of evidence supporting its effectiveness 2, 5
Ensure proper face mask fit covering both nose and mouth snugly, with research demonstrating its importance for optimal nebulization 4
Mix albuterol with ipratropium, cromolyn, or budesonide solutions if needed, with a strength of evidence supporting their additive effects 1, 5

For mild-to-moderate exacerbations, an MDI with valved holding chamber is equally effective, administering 4-8 puffs (90 mcg/puff = 360-720 mcg total) every 20 minutes for 3 doses, then every 1-4 hours as needed, with research supporting its effectiveness 2, 4

Monitor closely for adverse effects, including tachycardia, tremor, hypokalemia, and hyperglycemia, which are the primary concerns, with a strength of evidence supporting their association with albuterol treatment 1, 5
Maintain oxygen saturation >92% during treatment, with research demonstrating its importance for patient safety 3, 6

Levalbuterol 0.31-1.25 mg can be used as an alternative, administered at half the milligram dose of racemic albuterol with comparable efficacy, with a strength of evidence supporting its effectiveness 1, 4

Seek immediate medical advice if patient requires increasing frequency of treatments, with research supporting the importance of prompt intervention 5
Seek immediate medical advice if oxygen saturation remains <92% despite treatment, with research demonstrating its importance for patient safety 3
Seek immediate medical advice if patient shows signs of respiratory fatigue, altered mental status, or inability to speak in full sentences, with a strength of evidence supporting the importance of prompt intervention 2